Assess the potential positive cardiometabolic effects of specific psoriasis drug treatments in patients

Challenge

Understanding if specific treatments that demonstrated beneficial effects on cardiometabolic markers during randomized clinical trials can be shown using real world data, while controlling for confounders.

Solution

Leverage OM1 linked clinical EMR and claims data to better understand the role of specific Psoriasis treatments on longer-term cardiovascular comorbidities.

*Counts through Q2 2022